Jazz Pharmaceuticals plcJAZZ

Where JAZZ's P/E ratio sits inside its own 10-year distribution, with the yearly high, low and average.

$241.31+1.24 (+0.52%)Previous close
NASDAQHealthcare

JAZZ P/E ratio: current value, 10-year range and year-by-year history

16.5Below average

JAZZ's p/e ratio is lower than 65% of the last 10 years.

P/E ratio History

Historically priceyAbove avgAround avgBelow avgHistorically cheap
JAZZ P/E ratio historyJAZZ P/E ratio from Sep 2023 to Sep 2026: low -87.47, high 2,182.36, latest 16.49.-269.06389.191,047.441,705.72,363.95Sep 23Apr 24Nov 24Jul 25Feb 26Sep 26med 16.87

JAZZ P/E ratio by year

Yearly range of JAZZ’s p/e ratio from 2016 to 2026. Over the full period it ranged from -526.2 to 2,182.4, averaging 45.3.

JAZZ P/E ratio — yearly low, average, high and year-end values
YearLowAverageHighYear-end
2026-33.7709.72,182.416.5
2025-29.8-4.016.9-29.1
202414.019.524.514.0
2023-93.1-9.9152.8138.2
2022-526.2-179.9-18.8-524.4
2021-57.141.5194.5-23.4
20209.634.762.439.2
201911.314.919.616.4
201813.720.725.517.0
201717.422.424.922.2
201616.619.622.318.7

Get notified when JAZZ P/E ratio crosses a threshold

Free — one alert setup, notifications by push, Telegram, or Discord.

How much the market pays for each dollar of annual profit. P/E = Stock Price / EPS. The raw number means little — what matters is whether it's high or low relative to the company's own history.

FormulaPrice / Earnings Per Share
Full guide
How to read this chart

The chart shows five color-coded historical zones: green (below 10th percentile) means historically very cheap, fading through lime and gray (the normal 25th–75th range) to orange and red (historically expensive). When the line sits in a green or lime zone, the stock is trading at an unusually low P/E relative to its own history.

Key caveats
  • Cyclical businesses look cheapest on P/E at peak earnings — the "earnings trap." Use EV/EBITDA or normalised earnings for energy, materials, and financials.
  • A falling P/E trend may signal a business in structural decline, not a buying opportunity.

Is JAZZ P/E ratio High or Low Right Now?

Jazz Pharmaceuticals plc's P/E ratio is currently 16.5, which is below average relative to its 10-year historical range. The 10-year median P/E ratio for JAZZ is approximately 17.8. See all JAZZ valuation metrics →

Pro — up to 30-year history

Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.